Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care

被引：2
|
作者：
Parperis, Konstantinos [1 ,2 ]
机构：
[1] Univ Cyprus, Sch Med, Div Rheumatol, Internal Med, CY-1678 Nicosia, Cyprus
[2] Univ Arizona, Coll Med Phoenix, Med, Phoenix, AZ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷 / 12期
关键词：
gout; NSAIDs; treatment;
D O I：
10.1136/annrheumdis-2019-216643
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E202 / E202
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
    Hamidou, Mohamed
    Neel, Antoine
    Poupon, Joel
    Amoura, Zahir
    Ebbo, Mikael
    Sibilia, Jean
    Viallard, Jean-Francois
    Gaborit, Benjamin
    Volteau, Christelle
    Hardouin, Jean Benoit
    Hachulla, Eric
    Rieger, Francois
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [42] Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
    Mohamed Hamidou
    Antoine Néel
    Joel Poupon
    Zahir Amoura
    Mikael Ebbo
    Jean Sibilia
    Jean-Francois Viallard
    Benjamin Gaborit
    Christelle Volteau
    Jean Benoit Hardouin
    Eric Hachulla
    François Rieger
    Arthritis Research & Therapy, 23
  • [43] Re: Continuous Low-dose Antibiotic Prophylaxis for Adults with Repeated Urinary Tract Infections (AnTIC): A Randomized, Open-label Trial
    Kessler, Thomas M.
    EUROPEAN UROLOGY, 2019, 76 (05) : 708 - 708
  • [44] Randomised, controlled, open-label pragmatic trial evaluating changes in functional exercise capacity after primary care PUlmonary REhabilitation in patients with long COVID: protocol of the PuRe-COVID trial in Belgium
    Volckaerts, Tess
    Vissers, Dirk
    Burtin, Chris
    Van Meerbeeck, Xavier
    de Soomer, Kevin
    Oostveen, Ellie
    Claes, Kim
    Roelant, Ella
    Verhaegen, Iris
    Thomeer, Michiel
    Criel, Maarten
    Quadflieg, Kirsten
    Cops, Dries
    Ruttens, David
    Lapperre, Therese S.
    BMJ OPEN, 2023, 13 (06):
  • [45] Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial
    Jaishree Raman
    Elizabeth Allen
    Lesley Workman
    Aaron Mabuza
    Hendrik Swanepoel
    Gillian Malatje
    John Frean
    Lubbe Wiesner
    Karen I. Barnes
    Malaria Journal, 18
  • [46] A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Isatuximab, Pomalidomide, and Low-Dose Dexamethasone Versus Pomalidomide and Low-Dose Dexamethasone in Patients with Relapsed / Multiple Myeloma Refractory (RRMM)
    Niederwieser, Dietger
    Richardson, Paul
    Attal, Michel
    Rajkumar, Vincent
    San-Miguel, Jesus
    Beksac, Meral
    Spicka, Ivan
    Leleu, Xavier
    Schjesvold, Fredrik
    Moreau, Philippe
    Dimopoulosu, Meletios
    Huan, Jeffrey Shang-Yi
    Minarik, Jiri
    Cavo, Michele
    Mace, Sandrine
    Prince, H. Miles
    Corzo, Kathryn P.
    Campana, Frank
    Le-Guennec, Solenn
    Dubin, Franck
    Anderson, Kenneth C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 40 - 41
  • [47] Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial
    Raman, Jaishree
    Allen, Elizabeth
    Workman, Lesley
    Mabuza, Aaron
    Swanepoel, Hendrik
    Malatje, Gillian
    Frean, John
    Wiesner, Lubbe
    Barnes, Karen I.
    MALARIA JOURNAL, 2019, 18 (1)
  • [48] Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial
    Celia A. J. Michielsens
    Nadine Boers
    Nathan den Broeder
    Mark H. Wenink
    Aatke van der Maas
    Elien A. M. Mahler
    Michelle L. M. Mulder
    Désirée van der Heijde
    Frank H. J. van den Hoogen
    Lise M. Verhoef
    Alfons A. den Broeder
    Trials, 21
  • [49] Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial
    Michielsens, Celia A. J.
    Boers, Nadine
    den Broeder, Nathan
    Wenink, Mark H.
    van der Maas, Aatke
    Mahler, Elien A. M.
    Mulder, Michelle L. M.
    van der Heijde, Desiree
    van den Hoogen, Frank H. J.
    Verhoef, Lise M.
    ven Broeder, Alfons A.
    TRIALS, 2020, 21 (01)
  • [50] Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
    Lean, Michael E. J.
    Leslie, Wilma S.
    Barnes, Alison C.
    Brosnahan, Naomi
    Thom, George
    McCombie, Louise
    Peters, Carl
    Zhyzhneuskaya, Sviatlana
    Al-Mrabeh, Ahmad
    Hollingsworth, Kieren G.
    Rodrigues, Angela M.
    Rehackova, Lucia
    Adamson, Ashley J.
    Sniehotta, Falko F.
    Mathers, John C.
    Ross, Hazel M.
    McIlvenna, Yvonne
    Stefanetti, Renae
    Trenell, Michael
    Welsh, Paul
    Kean, Sharon
    Ford, Ian
    McConnachie, Alex
    Sattar, Naveed
    Taylor, Roy
    LANCET, 2018, 391 (10120): : 541 - 551
12345